Global Acute Intermittent Porphyria Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 152686
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 116
  • list Medical Devices

Acute intermittent porphyria (AIP) is a genetic metabolic disorder affecting the production of heme, the oxygen-binding prosthetic group of hemoglobin. It is characterized by a deficiency of the enzyme porphobilinogen deaminase.

Scope of the Report:

The worldwide market for Acute Intermittent Porphyria is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Acute Intermittent Porphyria in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Dahaner

Roche

Bio-Rad Laboratories

Siemens

ARKRAY

Sysmex Corporation

ACON Laboratories

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Gonadotropin-Releasing Hormone Analogues

Prophylactic Hematin Infusions

Market Segment by Applications, can be divided into

Hospitals & Clinics

Research Centers

There are 15 Chapters to deeply display the global Acute Intermittent Porphyria market.

Chapter 1, to describe Acute Intermittent Porphyria Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Acute Intermittent Porphyria, with sales, revenue, and price of Acute Intermittent Porphyria, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Acute Intermittent Porphyria, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Acute Intermittent Porphyria market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Acute Intermittent Porphyria sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Acute Intermittent Porphyria Introduction

1.2 Market Analysis by Type

1.2.1 Gonadotropin-Releasing Hormone Analogues

1.2.2 Prophylactic Hematin Infusions

1.3 Market Analysis by Applications

1.3.1 Hospitals & Clinics

1.3.2 Research Centers

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Dahaner

2.1.1 Business Overview

2.1.2 Acute Intermittent Porphyria Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Dahaner Acute Intermittent Porphyria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Roche

2.2.1 Business Overview

2.2.2 Acute Intermittent Porphyria Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Roche Acute Intermittent Porphyria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Bio-Rad Laboratories

2.3.1 Business Overview

2.3.2 Acute Intermittent Porphyria Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Bio-Rad Laboratories Acute Intermittent Porphyria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Siemens

2.4.1 Business Overview

2.4.2 Acute Intermittent Porphyria Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Siemens Acute Intermittent Porphyria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 ARKRAY

2.5.1 Business Overview

2.5.2 Acute Intermittent Porphyria Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 ARKRAY Acute Intermittent Porphyria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Sysmex Corporation

2.6.1 Business Overview

2.6.2 Acute Intermittent Porphyria Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Sysmex Corporation Acute Intermittent Porphyria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 ACON Laboratories

2.7.1 Business Overview

2.7.2 Acute Intermittent Porphyria Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 ACON Laboratories Acute Intermittent Porphyria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Acute Intermittent Porphyria Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Acute Intermittent Porphyria Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Acute Intermittent Porphyria Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Acute Intermittent Porphyria Manufacturer Market Share in 2017

3.3.2 Top 6 Acute Intermittent Porphyria Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Acute Intermittent Porphyria Market Analysis by Regions

4.1 Global Acute Intermittent Porphyria Sales, Revenue and Market Share by Regions

4.1.1 Global Acute Intermittent Porphyria Sales and Market Share by Regions (2013-2018)

4.1.2 Global Acute Intermittent Porphyria Revenue and Market Share by Regions (2013-2018)

4.2 North America Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

4.3 Europe Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

4.5 South America Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

5 North America Acute Intermittent Porphyria by Countries

5.1 North America Acute Intermittent Porphyria Sales, Revenue and Market Share by Countries

5.1.1 North America Acute Intermittent Porphyria Sales and Market Share by Countries (2013-2018)

5.1.2 North America Acute Intermittent Porphyria Revenue and Market Share by Countries (2013-2018)

5.2 United States Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

5.3 Canada Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

5.4 Mexico Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

6 Europe Acute Intermittent Porphyria by Countries

6.1 Europe Acute Intermittent Porphyria Sales, Revenue and Market Share by Countries

6.1.1 Europe Acute Intermittent Porphyria Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Acute Intermittent Porphyria Revenue and Market Share by Countries (2013-2018)

6.2 Germany Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

6.3 UK Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

6.4 France Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

6.5 Russia Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

6.6 Italy Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

7 Asia-Pacific Acute Intermittent Porphyria by Countries

7.1 Asia-Pacific Acute Intermittent Porphyria Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Acute Intermittent Porphyria Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Acute Intermittent Porphyria Revenue and Market Share by Countries (2013-2018)

7.2 China Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

7.3 Japan Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

7.4 Korea Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

7.5 India Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

8 South America Acute Intermittent Porphyria by Countries

8.1 South America Acute Intermittent Porphyria Sales, Revenue and Market Share by Countries

8.1.1 South America Acute Intermittent Porphyria Sales and Market Share by Countries (2013-2018)

8.1.2 South America Acute Intermittent Porphyria Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

8.3 Argentina Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

8.4 Colombia Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

9 Middle East and Africa Acute Intermittent Porphyria by Countries

9.1 Middle East and Africa Acute Intermittent Porphyria Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Acute Intermittent Porphyria Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Acute Intermittent Porphyria Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

9.3 UAE Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

9.4 Egypt Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

9.5 Nigeria Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

9.6 South Africa Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

10 Global Acute Intermittent Porphyria Market Segment by Type

10.1 Global Acute Intermittent Porphyria Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Acute Intermittent Porphyria Sales and Market Share by Type (2013-2018)

10.1.2 Global Acute Intermittent Porphyria Revenue and Market Share by Type (2013-2018)

10.2 Gonadotropin-Releasing Hormone Analogues Sales Growth and Price

10.2.1 Global Gonadotropin-Releasing Hormone Analogues Sales Growth (2013-2018)

10.2.2 Global Gonadotropin-Releasing Hormone Analogues Price (2013-2018)

10.3 Prophylactic Hematin Infusions Sales Growth and Price

10.3.1 Global Prophylactic Hematin Infusions Sales Growth (2013-2018)

10.3.2 Global Prophylactic Hematin Infusions Price (2013-2018)

11 Global Acute Intermittent Porphyria Market Segment by Application

11.1 Global Acute Intermittent Porphyria Sales Market Share by Application (2013-2018)

11.2 Hospitals & Clinics Sales Growth (2013-2018)

11.3 Research Centers Sales Growth (2013-2018)

12 Acute Intermittent Porphyria Market Forecast (2018-2023)

12.1 Global Acute Intermittent Porphyria Sales, Revenue and Growth Rate (2018-2023)

12.2 Acute Intermittent Porphyria Market Forecast by Regions (2018-2023)

12.2.1 North America Acute Intermittent Porphyria Market Forecast (2018-2023)

12.2.2 Europe Acute Intermittent Porphyria Market Forecast (2018-2023)

12.2.3 Asia-Pacific Acute Intermittent Porphyria Market Forecast (2018-2023)

12.2.4 South America Acute Intermittent Porphyria Market Forecast (2018-2023)

12.2.5 Middle East and Africa Acute Intermittent Porphyria Market Forecast (2018-2023)

12.3 Acute Intermittent Porphyria Market Forecast by Type (2018-2023)

12.3.1 Global Acute Intermittent Porphyria Sales Forecast by Type (2018-2023)

12.3.2 Global Acute Intermittent Porphyria Market Share Forecast by Type (2018-2023)

12.4 Acute Intermittent Porphyria Market Forecast by Application (2018-2023)

12.4.1 Global Acute Intermittent Porphyria Sales Forecast by Application (2018-2023)

12.4.2 Global Acute Intermittent Porphyria Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Acute Intermittent Porphyria Picture

Table Product Specifications of Acute Intermittent Porphyria

Figure Global Sales Market Share of Acute Intermittent Porphyria by

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery